Browse by Author Jia, W

TitleAuthor(s)YearView Count
Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4Ma, RCW; Hu, C; Tam, CH; Zhang, R; Kwan, P; Leung, TF; Thomas, GN; Go, MJ; Hara, K; Sim, X; Ho, JSK; Wang, C; Li, H; Lu, L; Wang, Y; Li, JW; Wang, Y; Lam, VKL; Wang, J; Yu, W; Kim, YJ; Ng, DP; Fujita, J; Panoutsopoulou, K; Day-Williams, AG; Lee, HM; Ng, ACW; Fang, YJ; Kong, APS; Jiang, F; Ma, X; Hou, X; Tang, S; Lu, J; Yamauchi, T; Tsui, SKW; Woo, J; Leung, PC; Zhang, X; Tang, NLS; Sy, HY; Liu, J; Wong, TY; Lee, JY; Maeda, S; Xu, G; Cherny, SS; Chan, TF; Ng, MCY; Xiang, K; Morris, AP; DIAGRAM Consortium,; Keildson, S; The MuTHER Consortium,; Hu, R; Li, J; Lin, X; Cho, YS; Kadowaki, T; Tai, ES; Zeggini, E; McCarthy, MI; Hon, KL; Baum, L; Tomlinson, B; So, WY; Bao, Y; Chan, JCN; Jia, W201329
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South AsiansLi, H; Kilpeläinen, TO; Liu, C; Zhu, J; Liu, Y; Hu, C; Yang, Z; Zhang, W; Bao, W; Cha, S; Wu, Y; Yang, T; Sekine, A; Choi, BY; Yajnik, CS; Zhou, D; Takeuchi, F; Yamamoto, K; Chan, JC; Mani, KR; Been, LF; Imamura, M; Nakashima, E; Lee, N; Fujisawa, T; Karasawa, S; Wen, W; Joglekar, CV; Lu, W; Chang, Y; Xiang, Y; Gao, Y; Liu, S; Song, Y; Kwak, SH; Shin, HD; Park, KS; Fall, CHD; Kim, JY; Sham, PC; Lam, KSL; Zheng, W; Shu, X; Deng, H; Ikegami, H; Krishnaveni, GV; Sanghera, DK; Chuang, L; Liu, L; Hu, R; Kim, Y; Daimon, M; Hotta, K; Jia, W; Kooner, JS; Chambers, JC; Chandak, GR; Ma, RC; Maeda, S; Dorajoo, R; Yokota, M; Takayanagi, R; Kato, N; Lin, X; Loos, RJF2012164
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in miceYe, D; Li, FYL; Lam, KSL; Li, H; Jia, W; Wang, Y; Man, K; Lo, CM; Li, X; Xu, A2012178
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551East and South AsiansLi, H; Kilpelainen, TO; Liu, C; Zhu, J; Liu, Y; Hu, C; Yang, Z; Zhang, W; Bao, W; Cha, S; Wu, Y; Yang, T; Sekine, A; Choi, BY; Yajnik, CS; Zhou, D; Takeuchi, F; Yamamoto, K; Chan, JC; Mani, KR; Been, LD; Imamura, M; Nakashima, E; Lee, N; Fujisawa, T; Karasawa, S; Wen, W; Joglikar, CV; Lu, W; Chang, Y; Xiang, Y; Gao, Y; Liu, S; Song, Y; Kwak, SH; Shin, HD; Park, KS; Fall, CHD; Kim, JY; Sham, PC; Lam, KSL; Zheng, W; Shu, X; Deng, H; Ikegami, H; Krishnaveni, GV; Sanghera, DK; Chuang, L; Liu, L; Hu, R; Kim, Y; Daimon, M; Hotta, K; Jia, W; Kooner, JS; Chambers, JC; Chandak, GR; Ma, RC; Maeda, S; Dorajoo, R; Yokota, M; Takayanagi, R; Kato, N; Lin, X; Loos, RJF201256
Toll-like receptor-4 mediated obesity-induced nonalcoholic steatohepatitis through activation on X-box binding protein-1 in miceYe, D; Li, FYL; Lam, KSL; Li, H; Jia, W; Wang, Y; Man, K; Lo, CY; Li, X; Xu, A201255
Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3Li, H; Gao, Z; Zhang, J; Ye, X; Xu, A; Ye, J; Jia, W201292
Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humansYu, H; Xia, F; Lam, KSL; Wang, Y; Bao, Y; Zhang, J; Gu, Y; Zhou, P; Lu, J; Jia, W; Xu, A2011292
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglycerideLi, H; Fang, Q; Gao, F; Fan, J; Zhou, J; Wang, X; Zhang, H; Pan, X; Bao, Y; Xiang, K; Xu, A; Jia, W201079
Serum fibroblast growth factor 21 is associated with adverse lipid profiles and γ-glutamyltransferase but not insulin sensitivity in Chinese subjectsLi, H; Bao, Y; Xu, A; Pan, X; Lu, J; Wu, H; Lu, H; Xiang, K; Jia, W200975
Li H, Bao Q, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K and Jia WP. Serum Fibroblast Growth Factor 21 is Associated with Adverse Lipid Profiles and γ-glutamyltransferase but not Insulin Sensitivity in Chinese Subjects.Li, H; Bao, Y; Xu, A; Pan, X; Lu, J; Wu, H; Xiang, K; Jia, W2009300